SET-to-Meet; Pilot Testing of a Nurse-led Intervention
SET-to-Meet
1 other identifier
interventional
97
1 country
2
Brief Summary
While interdisciplinary family meetings are evidence-based and part of usual care, this study seeks to test a novel set of implementation strategies (the SET-to-Meet intervention) to improve adherence to best practice guidelines for interdisciplinary family meetings. SET stands for Screen-Engage-Track; SET-to Meet is a nurse-led, team based intervention to ensure routine interdisciplinary family meetings are held on behalf of incapacitated, critically-ill patients in ICUs. This study is a feasibility and acceptability pilot test of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2019
CompletedFirst Posted
Study publicly available on registry
April 5, 2019
CompletedStudy Start
First participant enrolled
June 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMay 8, 2024
May 1, 2024
1.1 years
March 27, 2019
May 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Feasibility of training the staff for the intervention, as measured by percent of staff members completing on-line training
Feasibility of using online training will be assessed by percent of staff members who complete the on-line training during the two week training phase.
At the completion of the two week training phase which will occur immediately prior to initiating the 3-month pilot of the intervention
Feasibility of patient recruitment at the site, as measured by the volume of eligible patients admitted to the pilot ICU during the pilot phase.
Feasibility of recruitment will be assessed by the volume of eligible patient admitted to the pilot ICU.
At the conclusion of the 3-month pilot
Adherence to elements of intervention protocol
Adherence to steps in the intervention protocol for eligible patients will be assessed by review of tracking forms, questions to staff about patient screening and about engagement with family members, and direct observation of staff during interdisciplinary team rounds.
Throughout the 3 month pilot phase
Acceptability of the intervention to clinicians assessed via focus groups
Acceptability of the intervention will be evaluated using focus group sessions with physicians, social workers, care managers, and nurses. Using a semi-structured interview guide, we will elicit detailed information about staff satisfaction with the intervention; the clinician experience of participating in the intervention; staff-perceived value of the intervention to patients and families; and suggestions for improvement.
At the conclusion of the 3-month pilot
Clinician Satisfaction with the intervention assessed via on-line survey
Satisfaction of staff with: 1.) the intervention training and 2.) on-site support, as well as perceived value to patients/families and perceived burden of carrying out the intervention will be evaluated using a multi-item, likert-scale scored online survey sent to physicians, social workers, care managers, and nurses.
At the conclusion of the 3-month pilot
Secondary Outcomes (2)
Proportion of patients with a family meeting
At the conclusion of the 3-month pilot
Time elapsed until the first family meeting
At the conclusion of the 3-month pilot
Study Arms (1)
SET-to-MEET
EXPERIMENTALThis is a single arm, open trial that will be conducted in parallel in 3 separate ICUs. Each site will receive the SET-to-MEET intervention.
Interventions
The overall objective of this study is to pilot test, in advance of a larger randomized trial, a scalable, nurse-led intervention to ensure timely interdisciplinary family meetings are held on behalf of critically-ill ICU patients who cannot participate in discussions about their care.
Eligibility Criteria
You may qualify if:
- Patients: Individuals ≥18 year of age, admitted to the ICU for intensive care services at one of the 3 pilot sites during the pilot testing phase.
- Pilot site clinicians: nurses, care managers, social workers, and physicians who are employed/provide services in the pilot site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- Cambia Health Foundationcollaborator
Study Sites (2)
Excela Westmoreland Hospital
Greensburg, Pennsylvania, 15601, United States
West Penn Hospital
Pittsburgh, Pennsylvania, 15224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer B Seaman, PhD,RN,CHPN
University of Pittsburgh School of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, School of Nursing
Study Record Dates
First Submitted
March 27, 2019
First Posted
April 5, 2019
Study Start
June 13, 2019
Primary Completion
August 5, 2020
Study Completion
December 31, 2023
Last Updated
May 8, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- These will be made available beginning 9 months and ending 36 months following article publication.
- Access Criteria
- We will make this data available to collaborators whose proposed use of the data has been approved by an independent review committee.
This study will be conducted at sites within two different health systems, Allegheny Health Network and Excela Health, each with their own Institutional Review Board (IRB). The data use agreements with those respective organizations are pending, and we do not yet know the conditions and specifically, if and under what circumstances data sharing will be permitted. Provided data sharing is permitted, and in accordance with those agreements, academic collaborators of the Principal Investigator outside of the University of Pittsburgh may have access to participant data collected during the trial, after de-identification. These outside collaborators will obtain their own IRB approval for their role.